SGT-003

· Solid Biosciences Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SGT-003, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE) [Phase 3]